Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19.
Buyukozkan M, Alvarez-Mulett S, Racanelli AC, Schmidt F, Batra R, Hoffman KL, Sarwath H, Engelke R, Gomez-Escobar L, Simmons W, Benedetti E, Chetnik K, Zhang G, Schenck E, Suhre K, Choi JJ, Zhao Z, Racine-Brzostek S, Yang HS, Choi ME, Choi AMK, Cho SJ, Krumsiek J.
Buyukozkan M, et al.
iScience. 2022 Jul 15;25(7):104612. doi: 10.1016/j.isci.2022.104612. Epub 2022 Jun 17.
iScience. 2022.
PMID: 35756895
Free PMC article.